Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Chronic Hepatitis C Virus (HCV)”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableUnknownNCT00543244
What this trial is testing

Early Prediction of Successful Treatment for Chronic Hepatitis C Virus Infection in Taiwan

Who this might be right for
Chronic Hepatitis C
National Taiwan University Hospital 300
Testing effectiveness (Phase 2)Study completedNCT00559247
What this trial is testing

A Single Ascending Dose Study of BMS-650032 in HCV Infected Subjects

Who this might be right for
Chronic Hepatitis C
Bristol-Myers Squibb 24
Not applicableUnknownNCT04242433
What this trial is testing

HCV RAS Testing in Public Health Programs

Who this might be right for
Hepatitis CPublic HealthDirect Acting Antiviral Agents+1 more
Post Graduate Institute of Medical Education and Research, Chandigarh 200
Large-scale testing (Phase 3)Study completedNCT00378599
What this trial is testing

Effects of Pegylated Interferon Alfa-2b and Ribavirin After Orthotopic Liver Transplantation in Subjects With Chronic Hepatitis C Recurrence (P04590AM3)(COMPLETED)

Who this might be right for
Liver TransplantationHepatitis C, ChronicLiver Cirrhosis
Merck Sharp & Dohme LLC 125
Testing effectiveness (Phase 2)Study completedNCT01008358
What this trial is testing

Anti-CTLA-4 Human Monoclonal Antibody CP-675,206 in Patients With Advanced Hepatocellular Carcinoma

Who this might be right for
Hepatocellular CarcinomaHepatitis C Virus Chronic Infection
Clinica Universidad de Navarra, Universidad de Navarra 20
Post-approval studies (Phase 4)UnknownNCT02691728
What this trial is testing

Study to Investigate the Efficacy and Safety of Ledipasvir/Sofosbuvir Fixed-Dose Combination for 12 Weeks in Subjects With Chronic Genotype 1 and 4 HCV Infection With Autoimmune Disease

Who this might be right for
Chronic Hepatitis C
Peter J. Ruane, M.D., Inc. 40
Large-scale testing (Phase 3)Study completedNCT00780416
What this trial is testing

Efficacy and Safety of MP-424/Peginterferon Alfa-2b/Ribavirin Combination in Treatment-Naïve Patients With Chronic Hepatitis C

Who this might be right for
Hepatitis C
Tanabe Pharma Corporation 189
Large-scale testing (Phase 3)Study completedNCT00778843
What this trial is testing

Antioxidant and Immunomodulator Properties of Viusid in Patients With Chronic Hepatitis C

Who this might be right for
Chronic Hepatitis C
Catalysis SL 60
Testing effectiveness (Phase 2)Study completedNCT02480387
What this trial is testing

Efficacy and Safety of Ledipasvir/Sofosbuvir Fixed-Dose Combination for 8 Weeks in Subjects With Chronic Genotype 1 HCV and HIV-1 Co-infection

Who this might be right for
Treatment of Hepatitis C
Peter J. Ruane, M.D., Inc. 20
Early research (Phase 1)UnknownNCT01037621
What this trial is testing

Herpes Simplex Type 2 Co-infection in Veterans With Chronic Hepatitis C

Who this might be right for
Hepatitis C Virus InfectionInfectionHerpesvirus 2, Human
G.V. (Sonny) Montgomery VA Medical Center 50
Large-scale testing (Phase 3)WithdrawnNCT01641666
What this trial is testing

Safety and Tolerability of Boceprevir in Combination With Peginterferon Alfa-2b Plus Ribavirin for the Treatment of Vietnamese Subjects With Chronic Hepatitis C Genotype 1 (P08599)

Who this might be right for
Chronic Hepatitis C
Merck Sharp & Dohme LLC
Not applicableStudy completedNCT01272479
What this trial is testing

Prohepcidin, Inflammation and Iron Homeostasis in Hemodialysis Patients With Chronic Hepatitis C

Who this might be right for
Renal Failure Chronic Requiring HemodialysisHepatitis C
Istanbul University 80
Not applicableNot Yet RecruitingNCT06899542
What this trial is testing

HEPATITIS C SCREENING in ADULTS with RISK FACTORS in FIVE CITIES of COLOMBIA'S CARIBBEAN COAST (FIVE-CC)

Who this might be right for
Chronic Hepatitis C Infection
Diana Rocio Chavez Bejarano 4,000
Large-scale testing (Phase 3)Study completedNCT02358044
What this trial is testing

Efficacy and Safety of Combination Grazoprevir (MK-5172)/Elbasvir (MK-8742) Versus Sofosbuvir + Pegylated Interferon + Ribavirin in Hepatitis C Virus Genotype 1, 4 or 6 Infection (MK-5172-077)

Who this might be right for
Hepatitis C
Merck Sharp & Dohme LLC 257
Testing effectiveness (Phase 2)Study completedNCT00160251
What this trial is testing

Boceprevir (SCH 503034) Plus Peg-Intron, With and Without Added Ribavirin, in Patients With Chronic Hepatitis C, Genotype 1, Who Did Not Respond to Previous Treatment With Peginterferon Alfa Plus Ribavirin (Study P03659AM2)(COMPLETED)

Who this might be right for
Chronic Hepatitis C
Merck Sharp & Dohme LLC 357
Not applicableStudy completedNCT00606528
What this trial is testing

FGL2/Fibroleukin and Hepatitis C Virus Infection: A Predictor of Response to Antiviral Therapy

Who this might be right for
Chronic Hepatitis C Virus Infection
University Health Network, Toronto 54
Not applicableUnknownNCT04211844
What this trial is testing

Metabolic Changes in Chronic HCV Patients Receiving DAAS

Who this might be right for
Chronic Hepatitis C
Ain Shams University 100
Early research (Phase 1)Study completedNCT00905632
What this trial is testing

4 Week Combination of BI 207127 NA With Peg-IFN and Ribavirin in Chronic HCV Patients

Who this might be right for
Hepatitis C, Chronic
Boehringer Ingelheim 75
Testing effectiveness (Phase 2)Study completedNCT00546715
What this trial is testing

A Single Ascending Dose Study of Daclatasvir (BMS-790052) in Hepatitis C Virus Infected Subjects

Who this might be right for
Chronic Hepatitis C
Bristol-Myers Squibb 95
Large-scale testing (Phase 3)WithdrawnNCT01858961
What this trial is testing

Open Label Trial to Compare BI 207127 to Telaprevir in HCV Patients

Who this might be right for
Hepatitis C, Chronic
Boehringer Ingelheim
Next Page